{"id":"W2764071025","doi":"10.1111/apt.14368","title":"Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Bible College","funders":"Gastroenterological Society of Australia; AbbVie; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Therapeutic drug monitoring; Infliximab; Adalimumab; Inflammatory bowel disease; Intensive care medicine; Dosing; Drug; Biosimilar; Disease; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004008683,0.0009552251,0.00151205,0.0002121189,0.0001929812,0.00004333567,0.001038202,0.0003327519,0.0001362783],"category_scores_gemma":[0.000002465488,0.0008524828,0.000690289,0.0001125517,0.0004078671,0.00002101476,0.0002366456,0.0005128132,0.00004412997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001596295,"about_ca_system_score_gemma":0.0006126324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001407373,"about_ca_topic_score_gemma":0.000003447894,"domain_scores_codex":[0.9954658,0.001176262,0.001382943,0.0008806419,0.0003528293,0.0007415576],"domain_scores_gemma":[0.9971699,0.0001330003,0.001273715,0.001062341,0.0001316857,0.0002294113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002627711,0.004899539,0.1037363,0.05536633,0.05862429,0.001266035,0.0003685431,0.00006011498,0.05320577,0.00001467057,0.004338329,0.7154924],"study_design_scores_gemma":[0.005537295,0.0006676777,0.02466615,0.01897766,0.02033737,0.00002855661,0.00005905089,0.000009466458,0.01624745,0.0000352744,0.9111968,0.002237211],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1210341,0.8748527,3.421758e-7,0.0001114937,0.001073162,0.002317417,0.0005621457,0.00002869465,0.0000199654],"genre_scores_gemma":[0.01555138,0.9799373,0.00001757883,0.003186218,0.0003421043,0.0004075592,0.0002976918,0.0001670055,0.00009315474],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9068585,"threshold_uncertainty_score":0.9993926,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07897866906373673,"score_gpt":0.4131626218953791,"score_spread":0.3341839528316424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}